Webinar | August 24, 2022

Benefits Of Leveraging Real World Data (RWD) To Conduct Long-Term Follow Up

Source: Datavant

Conducting long term follow up studies to ensure that life-saving therapies can be brought to patients safely is challenging. This places a burden on patients participating in the studies and operational challenges on life sciences study sponsors.

Connecting sources of real world data (RWD) to clinical trials data can create a more seamless process for conducting long-term follow up studies.

In this webinar, panelists will discuss how this approach enables many benefits, including the ability to: 

  • Supplement data for patients lost to follow up
  • Augment trial data to help explain non-responders and adverse events 

This approach can be particularly beneficial in specific therapeutic areas, including: 

  • Cell and gene therapies: high regulatory burden (up to 15 years of data collection)
  • Oncology: endpoints such as overall survival can be assessed for Accelerated Approval
  • COVID-19: exploration of delayed adverse events
VIEW THE WEBINAR!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader